Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK3486 vs Propofol for General Anesthesia Induction
NCT04511728Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of cipepofol in general anesthesia, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Nov 2020; status: completed.
02
Drugs
cipepofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT04511728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04511728.